Internal Medicine, Hematology & Oncology · Houston, TX
NPI
1164755930
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
561 services
Medicare patients, 2024
190
Average age 73
Drug cost, 2024
$1.5M
168 prescriptions
Company payments, 2025
$9,550
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mehmet Altan was code 99215 (office e&m - established), 267 times for 115 patients. In total Mehmet Altan billed 561 services in 14 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 267 | 115 | $112.24 | $30K |
| 99214 Office E&M - Established | Facility | 95 | 58 | $71.68 | $6,810 |
| 99442 Telephone Services | Office | 63 | 33 | $71.42 | $4,500 |
| 99205 Office E&M - New | Facility | 61 | 61 | $143.45 | $8,750 |
| 99443 Telephone Services | Office | 31 | 23 | $100.11 | $3,103 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $104.55 | $1,150 |
By year: 2022 $49K for 519 services; 2023 $44K for 521 services; 2024 $56K for 561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mehmet Altan prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 37 prescriptions and refills. In total Mehmet Altan wrote 168 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 37 | 39 | Under 11 | $624K |
| Tepmetko Tepotinib Hcl | 19 | 19 | Under 11 | $447K |
| Ondansetron Hcl Generic | 14 | 14 | 11 | $75.64 |
| Alecensa Alectinib Hcl | 12 | 12 | Under 11 | $199K |
Brand drugs: 89 claims; generic drugs: 79 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mehmet Altan $9,550 ($9,550 in general payments such as food, travel and fees) from 6 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $6,774.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.